SavedAdd your journal

Journals / Marmara Medical Journal / 2026 / Volume: 21 Issue: 2

-

KRİTİK HASTALIK POLİNÖROPATİSİ VE MİYOPATİSİ

Kayıhan Uluç
Barış İşak
Tülin Tanrıdağ Tanrıdağ
Önder Us
Pages
—
Publication Date
2015-06-24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗

Abstract

-

Özet

Bilimsel zemin: Kritik hastalığın nöromusküler belirtileri olan polinöropati ve/veya miyopati, yoğun bakım ünitelerinde bir haftadan daha uzun süre yatan hastalarda gelişir. Sıklıkla altta yatan neden sepsis ve/veya çoklu organ yetmezliği veya steroid-nöromusküler kavşak bloke edici ilaç kullanımıdır. Özellikle ekstremite ve solunum kaslarında kuvvet kaybı ve uzamış mekanik ventilasyon ihtiyacına neden olurlar. Polinöropati akut ve aksonal tarzdadır, miyopati ise dört farklı tipte kendini gösterebilir. Genellikle bu hastalıklar gelişmeden önce görülen ensefalopati tablosu hastaların geç tanı almalarına sebebiyet vermektedir. İyi klinik izlem, erken evrede yapılacak elektrofizyolojik ve laboratuar çalışmalar, gerekli durumlarda alınacak biyopsi doğru tanıyı kolaylaştırır. Sıklıkla bir arada görülen bu hastalıkların erken evrede doğru tanı almaları ve ayırıcı tanılarının ayrıntılı yapılması önemlidir, çünkü bu sayede doğru tedavi uygulanabilir, ayrıca sağkalım üzerine doğrudan etkili olan bu hastalıklar ile mücadele edilebilinir. Çıkarımlar: Günümüzde daha iyi tanımlanmaya başlanan risk faktörlerinin elimine edilmesi bu hastalıkların görülebilirliklerini azaltabilir. Henüz özgül bir tedavi olmasa da, destekleyici tedaviler, sepsis ile agresif savaşım, hastalığa neden olabilecek medikal tedavilerin uzaklaştırılması hastaya yarar sağlayabilir. Anahtar Kelimeler: Kritik hastalık, polinöropati, miyopati

🔖

Cite This Article

Uluç, K., İşak, B., Tanrıdağ, T. T., Us, Ö. (2015). -. Marmara Medical Journal, Volume: 21 Issue: 2. https://ajindex.com/articles/1287101

References (193)

  1. Bolton CF. Neuromuscular manifestations of critical
  2. illness. Muscle Nerve 2005;32(2):140-163
  3. Visser LH. Critical illness polyneuropathy and
  4. myopathy: clinical features, risk factors and
  5. prognosis. Eur J Neurol 2006;13(11):1203-1212
  6. Hund E. Neurological complications of sepsis:critical
  7. illness polyneuropathy and myopathy. J Neurol;248:929-934
  8. Latronico N, Peli E, Botteri M. Critical illness
  9. myopathy and neuropathy. Curr Opin Crit Care;11(2):126-132
  10. Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ.
  11. Polyneuropathy in critically ill patients. J Neurol
  12. Neurosurg Psychiatry 1984;47:1223-1231
  13. Bolton CF, Laverty DA, Brown JD, Witt NJ, Hahn
  14. AF, Sibbald WJ. Critically ill polyneuropathy:
  15. electrophysiological studies and differentiation from
  16. Guillain-Barre syndrome. J Neurol Neurosurg
  17. Psychiatry 1986;49:563-573
  18. Leijten FS, De Weerd AW, Poortvliet DC, De Ridder
  19. VA, Ulrich C, Harink-De Weerd JE. Critical illness
  20. polyneuropathy in multiple organ dysfunction
  21. syndrome and weaning from the ventilator. Intensive
  22. Care Med 1996;22(9):856-861
  23. Witt NJ, Zochodne DW, Bolton CF, Grand'Maison F,
  24. Wells G, Young GB, Sibbald WJ. Peripheral nerve
  25. function in sepsis and multiple organ failure. Chest;99(1):176-184
  26. Tennila A, Salmi T, Pettila V, Roine RO, Varpula T,
  27. Takkunen O. Early signs of critical illness
  28. polyneuropathy in ICU patients with systemic
  29. inflammatory response syndrome or sepsis. Intensive
  30. Care Med 2000;26(9):1360-1363
  31. Druschky A, Herkert M, Radespiel-Troger M,
  32. Druschky K, Hund E, Becker CM, Hilz MJ, Erbguth
  33. F, Neundorfer B. Critical illness polyneuropathy:
  34. clinical findings and cell culture assay of
  35. neurotoxicity assessed by a prospective study.
  36. Intensive Care Med 2001;27(4):686-693
  37. Latronico N, Fenzi F, Recupero D, Guarneri B,
  38. Tomelleri G, Tonin P, De Maria G, Antonini L,
  39. Rizzuto N, Candiani A. Critical illness myopathy and
  40. neuropathy. Lancet 1996;347(9015):1579-1582
  41. Fenzi F, Latronico N, Refatti N, Rizzuto N. Enhanced
  42. expression of E-selectin on the vascular endothelium
  43. of peripheral nerve in critically ill patients with
  44. neuromuscular disorders. Acta Neuropathol (Berl);106(1):75-82
  45. de Letter MA, Schmitz PI, Visser LH, Verheul FA,
  46. Schellens RL, Op de Coul DA, van der Meche FG.
  47. Risk factors for the development of polyneuropathy
  48. and myopathy in critically ill patients. Crit Care Med;29(12):2281-2286
  49. Sander HW, Golden M, Danon MJ. Quadriplegic
  50. areflexic ICU illness: selective thick filament loss and
  51. normal nerve histology. Muscle Nerve;26(4):499-505
  52. Verheul GA, de Jongh-Leuvenink J, Op de Coul AA,
  53. van Landeghem AA, van Puyenbroek MJ. Tumor
  54. necrosis factor and interleukin-6 in critical illness
  55. polyneuromyopathy. Clin Neurol Neurosurg;96(4):300-304
  56. Coakley JH, Nagendran K, Yarwood GD, Honavar M,
  57. Hinds CJ. Patterns of neurophysiological abnormality
  58. in prolonged critical illness. Intensive Care Med;24(8):801-807
  59. Zifko UA, Zipko HT, Bolton CF. Clinical and
  60. electrophysiological findings in critical illness
  61. polyneuropathy. J Neurol Sci 1998;159(2):186-193
  62. Op de Coul AA, Lambregts PC, Koeman J, van
  63. Puyenbroek MJ, Ter Laak HJ, Gabreels-Festen AA.
  64. Neuromuscular complications in patients given
  65. Pavulon (pancuronium bromide) during artificial
  66. ventilation. Clin Neurol Neurosurg 1985;87(1):17-22
  67. Kupfer Y, Namba T, Kaldawi E, Tessler S. Prolonged
  68. weakness after long-term infusion of vecuronium
  69. bromide. Ann Intern Med 1992;117(6):484-486
  70. Khan J, Harrison TB, Rich MM, Moss M. Early
  71. development of critical illness myopathy and
  72. neuropathy in patients with severe sepsis. Neurology;67(8):1421-1425
  73. Low PA NK, Seionti L. Role of hypoxia, oxidative
  74. stress, and excitatory neurotoxins in diabetic
  75. neuropathy. In: Dyck PJ TP, editor. Diabetic
  76. neuropathy. 2nd ed. Philadelphia: WB Saunders;
  77. p 317-329
  78. Maher J, Rutledge F, Remtulla H, Parkes A, Bernardi
  79. L, Bolton CF. Neuromuscular disorders associated
  80. with failure to wean from the ventilator. Intensive
  81. Care Med 1995;21(9):737-743
  82. Sander HW, Saadeh PB, Chandswang N, Greenbaum
  83. D, Chokroverty S. Diaphragmatic denervation in
  84. intensive care unit patients. Electromyogr Clin
  85. Neurophysiol 1999;39(1):3-5
  86. Hund E, Genzwurker H, Bohrer H, Jakob H, Thiele R,
  87. Hacke W. Predominant involvement of motor fibres
  88. in patients with critical illness polyneuropathy. Br J
  89. Anaesth 1997;78(3):274-278
  90. Rich MM, Teener JW, Raps EC, Schotland DL, Bird
  91. SJ. Muscle is electrically inexcitable in acute
  92. quadriplegic myopathy. Neurology 1996;46(3):731-
  93. Zochodne DW, Bolton CF, Wells GA, Gilbert JJ,
  94. Hahn AF, Brown JD, Sibbald WA. Critical illness
  95. polyneuropathy. A complication of sepsis and
  96. multiple organ failure. Brain 1987;110 ( Pt 4):819-
  97. Lycklama J NA, Troost J. Critical illness
  98. polyneuropathy. In: WB M, editor. Handbook of
  99. clinical neurology. New York: Elsevier Science;
  100. p 129-135
  101. Dellinger RP, Carlet JM, Masur H, Gerlach H,
  102. Calandra T, Cohen J, Gea-Banacloche J, Keh D,
  103. Marshall JC, Parker MM, Ramsay G, Zimmerman JL,
  104. Vincent JL, Levy MM. Surviving Sepsis Campaign
  105. guidelines for management of severe sepsis and septic
  106. shock. Intensive Care Med 2004;30(4):536-555
  107. Lowry SF. Sepsis and its complications: clinical
  108. definitions and therapeutic prospects. Crit Care Med;22(7):S1-2
  109. Marmara Medical Journal 2008;21(2);193-202
  110. Kayıhan Uluç, Ark.
  111. Kritik hastalık polinöropatisi ve miyopatisi
  112. Garnacho-Montero J, Madrazo-Osuna J, GarciaGarmendia
  113. JL, Ortiz-Leyba C, Jimenez-Jimenez FJ,
  114. Barrero-Almodovar A, Garnacho-Montero MC,
  115. Moyano-Del-Estad MR. Critical illness
  116. polyneuropathy: risk factors and clinical
  117. consequences. A cohort study in septic patients.
  118. Intensive Care Med 2001;27(8):1288-1296
  119. Bolton CF, Young GB, Zochodne DW. The
  120. neurological complications of sepsis. Ann Neurol;33(1):94-100
  121. van der Schaaf M, Beelen A, de Groot IJ. Critical
  122. illness polyneuropathy: a summary of the literature on
  123. rehabilitation outcome. Disabil Rehabil;22(17):808-810
  124. van der Schaaf M, Beelen A, de Vos R. Functional
  125. outcome in patients with critical illness
  126. polyneuropathy. Disabil Rehabil 2004;26(20):1189-
  127. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de
  128. Weerd AW. The role of polyneuropathy in motor
  129. convalescence after prolonged mechanical ventilation.
  130. Jama 1995;274(15):1221-1225
  131. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann
  132. S. Effects of early treatment with immunoglobulin on
  133. critical illness polyneuropathy following multiple
  134. organ failure and gram-negative sepsis. Intensive Care
  135. Med 1997;23(11):1144-1149
  136. van den Berghe G, Wouters P, Weekers F, Verwaest
  137. C, Bruyninckx F, Schetz M, Vlasselaers D,
  138. Ferdinande P, Lauwers P, Bouillon R. Intensive
  139. insulin therapy in the critically ill patients. N Engl J
  140. Med 2001;345(19):1359-1367
  141. Van den Berghe G, Schoonheydt K, Becx P,
  142. Bruyninckx F, Wouters PJ. Insulin therapy protects
  143. the central and peripheral nervous system of intensive
  144. care patients. Neurology 2005;64(8):1348-1353
  145. Langouche L, Vanhorebeek I, Vlasselaers D, Vander
  146. Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van
  147. den Berghe G. Intensive insulin therapy protects the
  148. endothelium of critically ill patients. J Clin Invest;115(8):2277-2286
  149. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters
  150. PJ, Van den Berghe G. Contribution of circulating
  151. lipids to the improved outcome of critical illness by
  152. glycemic control with intensive insulin therapy. J Clin
  153. Endocrinol Metab 2004;89(1):219-226
  154. Douglass JA, Tuxen DV, Horne M, Scheinkestel CD,
  155. Weinmann M, Czarny D, Bowes G. Myopathy in
  156. severe asthma. Am Rev Respir Dis 1992;146(2):517-
  157. Campellone JV, Lacomis D, Kramer DJ, Van Cott
  158. AC, Giuliani MJ. Acute myopathy after liver
  159. transplantation. Neurology 1998;50(1):46-53
  160. Perea M, Picon M, Miro O, Orus J, Roig E, Grau JM.
  161. Acute quadriplegic myopathy with loss of thick
  162. (myosin) filaments following heart transplantation. J
  163. Heart Lung Transplant 2001;20(10):1136-1141
  164. Rich MM, Pinter MJ, Kraner SD, Barchi RL. Loss of
  165. electrical excitability in an animal model of acute
  166. quadriplegic myopathy. Ann Neurol 1998;43(2):171-
  167. Rich MM, Pinter MJ. Sodium channel inactivation in
  168. an animal model of acute quadriplegic myopathy.
  169. Ann Neurol 2001;50(1):26-33
  170. Rich MM, Pinter MJ. Crucial role of sodium channel
  171. fast inactivation in muscle fibre inexcitability in a rat
  172. model of critical illness myopathy. J Physiol;547(Pt 2):555-566
  173. Brealey D, Brand M, Hargreaves I, Heales S, Land J,
  174. Smolenski R, Davies NA, Cooper CE, Singer M.
  175. Association between mitochondrial dysfunction and
  176. severity and outcome of septic shock. Lancet;360(9328):219-223
  177. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA,
  178. Fischer JE, Hasselgren PO. Sepsis is associated with
  179. increased mRNAs of the ubiquitin-proteasome
  180. proteolytic pathway in human skeletal muscle. J Clin
  181. Invest 1997;99(2):163-168
  182. Sher JH, Shafiq SA, Schutta HS. Acute myopathy
  183. with selective lysis of myosin filaments. Neurology;29(1):100-106
  184. Showalter CJ, Engel AG. Acute quadriplegic
  185. myopathy: analysis of myosin isoforms and evidence
  186. for calpain-mediated proteolysis. Muscle Nerve;20(3):316-322
  187. Sitwell LD, Weinshenker BG, Monpetit V, Reid D.
  188. Complete ophthalmoplegia as a complication of acute
  189. corticosteroid- and pancuronium-associated
  190. myopathy. Neurology 1991;41(6):921-922
  191. Zochodne DW, Ramsay DA, Saly V, Shelley S,
  192. Moffatt S. Acute necrotizing myopathy of intensive
  193. care: electrophysiological studies. Muscle Nerve;17(3):285-292